| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
COVID-19 vaccine hesitancy among health care worker-parents (HCWP) in Puducherry, India and its implications on their children: A cross sectional descriptive study
|
Sarkar, Pratik
|
|
|
40 |
40 |
p. 5821-5827
|
artikel
|
| 2 |
Development and validation of a COVID-19 vaccine hesitancy scale for adults in the United States
|
Hrin, Matthew L.
|
|
|
40 |
40 |
p. 5764-5768
|
artikel
|
| 3 |
Editorial Board/Aims and Scope
|
|
|
|
40 |
40 |
p. IFC
|
artikel
|
| 4 |
Enhancement of live vaccines by co-delivery of immune modulating proteins
|
Manohar, Megha M.
|
|
|
40 |
40 |
p. 5769-5780
|
artikel
|
| 5 |
“Every interaction you have …should be an opportunity to discuss and offer influenza vaccination”. Health service perspectives on influenza vaccination promotion and delivery to Aboriginal families living in New South Wales, Australia
|
Bolsewicz, Katarzyna T.
|
|
|
40 |
40 |
p. 5814-5820
|
artikel
|
| 6 |
First-in-human assessment of safety and immunogenicity of low and high doses of Plasmodium falciparum malaria protein 013 (FMP013) administered intramuscularly with ALFQ adjuvant in healthy malaria-naïve adults
|
Hutter, Jack N
|
|
|
40 |
40 |
p. 5781-5790
|
artikel
|
| 7 |
Immune non-interference and safety study of Vi-DT typhoid conjugate vaccine with a measles, mumps and rubella containing vaccine in 9–15 months old Nepalese infants
|
Saluja, Tarun
|
|
|
40 |
40 |
p. 5828-5834
|
artikel
|
| 8 |
Intranasal immunization with recombinant Vaccinia virus encoding trimeric SARS-CoV-2 spike receptor-binding domain induces neutralizing antibody
|
Cao, Xiaoling
|
|
|
40 |
40 |
p. 5757-5763
|
artikel
|
| 9 |
Making more COVID-19 vaccines available to address global needs: Considerations and a framework for their evaluation
|
Krause, Philip R
|
|
|
40 |
40 |
p. 5749-5751
|
artikel
|
| 10 |
Neutralizing antibody responses in healthcare personnel after three doses of mRNA BNT162b2 vaccine and association with baseline characteristics and past SARS-CoV-2 infection
|
Psaridi, Loukia
|
|
|
40 |
40 |
p. 5752-5756
|
artikel
|
| 11 |
No significant increase in Guillain-Barré syndrome after COVID-19 vaccination in adults: A vaccine adverse event reporting system study
|
Jaffry, M.
|
|
|
40 |
40 |
p. 5791-5797
|
artikel
|
| 12 |
Persistence of protective anti-poliovirus antibody levels in 4-year-old children previously primed with Picovax®, a trivalent, aluminium-adjuvanted reduced dose inactivated polio vaccine
|
Sáez-Llorens, Xavier
|
|
|
40 |
40 |
p. 5835-5841
|
artikel
|
| 13 |
Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults
|
Fraiman, Joseph
|
|
|
40 |
40 |
p. 5798-5805
|
artikel
|
| 14 |
Vaccine efficacy trials for Crimean-Congo haemorrhagic fever: Insights from modelling different epidemiological settings
|
Vesga, Juan F.
|
|
|
40 |
40 |
p. 5806-5813
|
artikel
|
Tijdschrift beschrijving